Indications for use:
Recommended for patients with signs of chronoaging, structural exhaustion and gravitational ptosis of the skin:
- Pronounced sagging skin, loss of its density and structural weakening.
- Presence of fine lines, deep static wrinkles and folds.
- Deficiency and loss of volume in the middle and lower thirds of the face.
- Tissue ptosis, loss of clarity of contours and deformation of the facial oval.
- Progressive deterioration of the overall quality, elasticity and texture of the skin.
Composition:
Sterile, dermatologically tested and fully biocompatible formula with optimized rheological parameters:
- Calcium hydroxyapatite (CaHA): 300 mg per syringe. Acts as the main stimulator of neocollagenesis. The concentration of the active substance is 100 mg/ml.
- Sodium Hyaluronate (HA): Presented as a stabilized viscoelastic HA matrix with a high elasticity index G'. Acts as a gel carrier for uniform distribution of microspheres and immediate tissue hydration.